Patents by Inventor Frank Brietling

Frank Brietling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of tumors using specific anti-L1 antibody
    Patent number: 8580258
    Abstract: The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.
    Type: Grant
    Filed: February 6, 2012
    Date of Patent: November 12, 2013
    Assignees: Deutsches krebsforschungszentrum Stiftung des Offentlichen Rechts, Medigene AG
    Inventors: Daniela Kelm, Peter Altevogt, Gerhard Moldenhauer, Frank Brietling, Achim Krueger, Silke Wolterink, Sandra Luettgau, Ulrich Moebius, Yi Li, Susanne Sebens, Heiner Schaefer
  • TREATMENT OF TUMORS USING SPECIFIC ANTI-L1 ANTIBODY
    Publication number: 20120258039
    Abstract: The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.
    Type: Application
    Filed: February 6, 2012
    Publication date: October 11, 2012
    Inventors: Daniela Gast, Peter Altevogt, Gerhard Moldenhauer, Frank Brietling, Achim Krüger, Silke Wolterink, Sandra Lüttgau, Ulrich Mõbius, Yi Li
  • Treatment of tumors using specific anti-L1 antibody
    Patent number: 8138313
    Abstract: The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.
    Type: Grant
    Filed: June 13, 2008
    Date of Patent: March 20, 2012
    Assignees: Deutsches Krebsforschungszentrum Stiftung des offentlichen Rechts, MediGene AG
    Inventors: Daniela Kelm, Peter Altevogt, Gerhard Moldenhauer, Frank Brietling, Achim Krüger, Silke Bärreiter, Sandra Lüttgau, Ulrich Möbius, Yi Li
  • TREATMENT OF TUMORS USING SPECIFIC ANTI-L1 ANTIBODY
    Publication number: 20090162355
    Abstract: The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.
    Type: Application
    Filed: June 13, 2008
    Publication date: June 25, 2009
    Inventors: Daniela Gast, Peter Altevogt, Gerhard Moldenhauer, Frank Brietling, Achim Kruger, Silke Wolterink, Sandra Luttgau, Ulrich Mobius, Yi Li